Rhaeos is a clinical stage digital health and medical technology company developing FlowSense, a platform noninvasive wireless, wearable skin sensor that can assess bodily fluid flow beneath the skin’s surface in the hospital and home. The company is initially targeting hydrocephalus, a chronic neurological condition caused by an abnormal accumulation of cerebrospinal fluid (CSF) on the brain. Pipeline applications in oncology and dialysis are in development.

HLTH does not sell or provide any personal data (including email, phone, address) to any third parties and we never will. Any communication that pretends to be HLTH or any third parties selling purported lists, discounted rooms, or any product/services are NOT AFFILIATED with HLTH and are to be considered FRAUD.

Upcoming Event Dates

2024 | ViVE: Feb 25-28; HLTH Europe: Jun 17-20; HLTH US: Oct 20-23

2025 | ViVE: Feb 16-19; HLTH US: Oct 19-22

2026 | HLTH US: Nov 15-18

2027 | HLTH US: Oct 17-20

© 2024 HLTH, INC. All Rights Reserved